Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04743661
Title 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pediatric Brain Tumor Consortium
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.